Resource Center
Resource Center
Pilot study in Kenya demonstrates that near point-of-care #HPV testing can be successfully integrated into cervical cancer screening programs
Read more
Background Hypoxemia, characterized by low oxygen levels in the blood, contributes to over 800,000 preventable global deaths annually, particularly among children and neonates. Inadequate provider skills and oxygen supply management systems have hindered the timely diagnosis and treatment of hypoxemia, resulting in avoidable fatalities. This program, in partnership with the Ministry of Health and CHAI,...
Read moreEthiopia's Oxygen Roadmap created a solid foundation for coordinating and mobilizing resources for COVID-19 response and maintaining essential services
Read morePublic health sector centralized oxygen plant makes oxygen more affordable for facilities in Cambodia
Read more
Climate change was in the spotlight as world leaders and experts met during the UN General Assembly (UNGA) in New York City, last week. “We are all dying from climate change,” Dr. Vanessa Kerry, the WHO special envoy for climate change and health told Devex. The UN Secretary General Antonio Guterres put it more forcefully,...
Read more
The Africa CDC, CHAI, and PATH have released a briefing paper, “Current and planned vaccine manufacturing in Africa,” following an assessment of vaccine manufacturing capacity in Africa
Read moreThis study of Africa’s current and planned vaccine manufacturing capacity offers insights into how to target investments and development efforts to promote long-term success.
Read moreResults from a joint assessment by Africa CDC, CHAI, and PATH of current and planned vaccine manufacturing in Africa.
Read more
The Missing Billion Initiative, the McKinsey Health Institute, the Clinton Health Access Initiative, the International Disability Alliance, and the London School of Hygiene & Tropical Medicine have partnered to accelerate disability inclusion in health systems globally.
Read moreThe Global Antibiotic Research & Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have signed a sublicense agreement to manufacture cefiderocol, an antibiotic to treat certain Gram-negative infections.
Read more